Intendis is a specialized pharmaceutical company focused on the Dermatologicals category. Headquartered in Berlin, Germany the company was founded in 2005 as a subsidiary of Schering AG. Intendis has a successful track record of providing prescription drug products for the treatment of severe skin diseases and was a pioneer in the development of locally applicable corticosteroid treatments.
| Website | http://intendis.com |
| Revenue | $5 million |
| Employees | 15 (14 on RocketReach) |
| Phone | +1 973-487-2096 |
| Technologies |
JavaScript
,
HTML
,
reCAPTCHA
+19 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Drug Manufacturing & Research, Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare |
| Keywords | Pharmaceutical Dermatology, Medical Dermatology, Clinical Dermatology, Skin Health Solutions, Skincare Treatments, Dermatology Products, Dermatological Care, Topical Medications, Advanced Dermatology, Skin Disease Treatment, Cosmetic Dermatology, Skincare Science, Prescription Medications, Drug Development, Pharmaceutical Research |
| Competitors | Ipsen, Galderma, Revance, Actavis plc (now Allergan), Sientra, Inc., Medytox, Hugel Inc. +32 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 2834 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular Intendis employee's phone or email?
The Intendis annual revenue was $5 million in 2026.
Gary Tighe is the Vice President Sales and Managed Markets of Intendis.
14 people are employed at Intendis.
The NAICS codes for Intendis are [3254, 325, 32, 32541].
The SIC codes for Intendis are [28, 2834, 283].